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“Programmed cell death or ‘apoptosis’ is critical for organ-
ogenesis during embryonic development and tissue ho-
meostasis in the adult. Its deregulation can contribute
to a broad range of human pathologies, including neurode-
generation, cancer, or autoimmunity…” These or similar
phrases have become generic opening statements inmany
reviews and textbooks describing the physiological rele-
vance of apoptotic cell death. However, while the role in
disease has been documented beyond doubt, facilitating
innovative drug discovery, wewonder whether the former
is really true. What goes wrong in vertebrate development
or in adult tissue when the main route to apoptotic cell
death, controlled by the BCL2 family, is impaired? Such
scenarios have been mimicked by deletion of one or
more prodeath genes within the BCL2 family, and gene
targeting studies in mice exploring the consequences
have beenmanifold.Many of these studies were geared to-
ward understanding the role of BCL2 family proteins and
mitochondrial apoptosis in disease, whereas fewer fo-
cused in detail on their role during normal development
or tissue homeostasis, perhaps also due to an irritating
lack of phenotype. Looking at these studies, the relevance
of classical programmed cell death by apoptosis for
development appears rather limited. Together, these
many studies suggest either highly selective and con-
text-dependent contributions of mitochondrial apoptosis
or significant redundancy with alternative cell death
mechanisms, as summarized and discussed here.
BCL2, the foundingmember of the BCL2 family, was iden-
tified30years agouponcharacterizationof a frequentlyob-
served t14,18 chromosomal translocation in follicular
lymphoma (Cleary et al. 1986; Tsujimoto and Croce
1986). After realizing that the presumed oncogenic poten-
tial of this gene lies within its anti-apoptotic property
(Vaux et al. 1988), a number of related proteins were iden-
tified in protein–protein interaction screens, by sequence
similarity, and/or by structural homology in humans as
well as different vertebrate model organisms and viral
pathogens. Some of these proteins exert inherent prosur-
vival function by blocking apoptosis, and some of them
may even be converted into killers by limited proteolysis
or upon alternative splicing of the encodingRNAor act ex-
clusively as inducers of cell death (Tait and Green 2013;
Czabotar et al. 2014). Orthologs of these proteins found
in nematodes regulate apoptosis during embryonic devel-
opment and upon exogenous stress in the germline, but
molecular details do differ substantially from vertebrates,
while, in insects,moredistantBCL2 relatives seemtohave
no role in apoptosis regulation at all. In fact, it seems that
“intrinsic” or “mitochondrial” BCL2-regulated apoptosis
has been specially tuned to fit the needs of vertebrates
(Bender et al. 2012). For more detailed information on the
history of the discovery of the extended BCL2 family, we
refer the interested reader to a recent comprehensive
“time-line” article by Delbridge et al. (2016).
Next to anti-apoptotic BCL2, BCLXL, BCLW, BCLB,
MCL1, andA1/BFL1, cell death-inducing familymembers
include apical “BH3-only” proteins (e.g., BIM, PUMA, or
BID) that act as preformed sentinels or are induced tran-
scriptionally in response to stress as well as BAX-like pro-
teins that control mitochondrial outer membrane (MOM)
integrity. Once activated, BAX and related BAK can pro-
moteMOMpermeabilization (MOMP) by pore formation,
much like some bacterial toxins (Garcia-Saez et al. 2010)
or phage-derived holins do (Pang et al. 2011), causing the
release of “danger signals” from the intermitochondrial
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membrane space, including cytochrome c and inhibitor of
apoptosis protein (IAP) antagonists such as SMAC/DIA-
BLO (Tait and Green 2013). This leads to the activation
and amplification of a proteolytic cascade, initiated and
executed by endopeptidases of the caspase family. Along
this route, caspases orchestrate largely immunologically
silent cell death (and may even induce tolerance), con-
trasting their role in other, proinflammatory cell death
paradigms (Martin et al. 2012). Although not all apoptotic
cell death needs to be immunologically silent, it is fair to
say that apoptosis occurring during vertebrate develop-
ment indeed is. This is most likely also true in tissue ho-
meostasis in the adult, where apoptosis aims to maintain
steady state in the absence of injury or other types of stress
(Martin et al. 2012).
Numerous studies have explored the role of anti-
apoptotic BCL2 proteins in mouse development, and the
consequences of loss of function of these proteins—high-
lighting tissue and cell type-specific prosurvival function
of these proteins—have been reviewed recently elsewhere
(Sochalska et al. 2015). Clearly, these studies pinpoint
that probably all cell types, even platelets, rely on apopto-
sis inhibition by different BCL2 family proteins during
their development or in the adult. But what about the oth-
er side of the coin? What can we learn about physiology
(rather than pathophysiology) when we block apoptosis?
This review summarizes the consequences of impaired
apoptotic cell death in vertebrate development and tissue
homeostasis, largely based onmouse studies, and discuss-
es possible explanations for the overall limited impact of
apoptosis deficiency on these processes. We close with
some possibly provocative thoughts about putative redun-
dancies among the different cell death machineries de-
scribed today (Fig. 1) and lines of research that might
address these possibilities.
Mitochondrial apoptosis: initiation, execution,
and the enigmatic apoptotic pore
Intense research over the past decades has shaped a rea-
sonably sharp picture of how prodeath BCL2 proteins ini-
tiate and execute mitochondrial apoptosis via MOMP
(Fig. 2). The early “rheostatmodel” proposed that the ratio
of proapoptotic and anti-apoptotic proteins in a given cell
known at that time—e.g., BCL2:BAX (or other combina-
tions)—defines cellular destiny (Oltvai et al. 1993; Sedlak
et al. 1995). This model had to be dismissed soon due to
the discovery that BH3-only proteins can promote apopto-
sis by direct interaction with BCL2 prosurvival proteins,
displacing BAX (Yang et al. 1995; Wang et al. 1996). The
“neutralization”model of mitochondrial apoptosis hence
suggested that BAX/BAK are constitutively active when
all BCL2-like proteins present in a given cell are neutral-
ized by direct engagement with BH3-only proteins that
display different affinities for the former (Chen et al.
2005; Willis et al. 2005, 2007). This model had some com-
petition based on findings that some BH3-only proteins,
such as truncated BID (tBID) (Wang et al. 1996) or BIM,
can trigger BAX/BAK conformational changes and activa-
tion by direct, albeit transient, interaction (Cheng et al.
2001; Letai et al. 2002; Kuwana et al. 2005). The ensuing
“direct activation” model (Kim et al. 2006; Brunelle and
Letai 2009) built on these parallel observations and gained
much support by additional studies making use of full-
length recombinant proteins to study permeabilization
of artificial lipid vesicles in the absence or presence of mi-
tochondria-specific lipids (in particular cardiolipin) but
also whole mitochondria. These observations formed
the basis of the “embedded together” model (Lovell
et al. 2008), which incorporated the role of the mitochon-
drial membrane in the regulation of the interactions be-
tween Bcl-2 proteins in an advanced version of the
“direct activation”model (Fig. 2; Bogner et al. 2010). Fur-
thermore, the generation of “BH3 domain swapmutants,”
where BH3 domains of different origin (e.g., those derived
from BAD, PUMA, or NOXA)were grafted into themouse
Bim gene locus, provided long-sought-after in vivo evi-
dence for thismodel (Merino et al. 2009). Previous nuclear
magnetic resonance (NMR) (Walensky et al. 2006; Gava-
thiotis et al. 2008) and crystallography-based structural
studies also suggested that a conformational change in
BAX (and BAK) triggered by direct BH3-only protein bind-
ing is crucial to generate the minimum functional unit of
these proteins (Czabotar et al. 2013; Brouwer et al. 2014),
referred to as the “BH3 in groove” symmetric homodimer
(involving helices α2–α5). Dimer formation in the MOM
leads to the exposure of additional contact sites, likely in-
volving helices 6 and 9 and allowing formation of higher-
order oligomers between individual dimers that can span
the MOM like a clamp (Bleicken et al. 2014). This culmi-
nates in the progressive assembly of a toroidal pore (a mix
of proteins and lipids) that was visualized only recently in
elegant studies using superresolution microscopy and
stimulated emission depletion (STED) nanoscopy (Grosse
et al. 2016; Salvador-Gallego et al. 2016). Of note, an auto-
inhibited BAX dimer has been described recently to be
present in the cytosol (Garner et al. 2016). This dimer con-
formation needs to be broken up to allow BAX activation,
translocation, and accumulation in the MOM. However,
this process is antagonized in healthy cells by continuous
BCL2/BCLX-driven retrotranslocation of heterodimers
back into the cytosol (Edlich et al. 2011; Todt et al.
2015), while retention at the MOM is facilitated by mem-
brane-resident VDAC2 and BAK (Ma et al. 2014), adding
additional layers of complexity to apoptosis regulation
(Fig. 2).
However, to the delight of some but dismay of others,
the requirement of BH3-only proteins for direct BAX/
BAK activation needs to be reconsidered (Garcia Saez
and Villunger 2016). First of all, in an attempt to reconcile
all of these models, it became evident that BCL2 proteins
can engage BH3-only proteins as well as activated BAX/
BAK with high affinity (Llambi et al. 2011). Along that
line, a recent study combining structural biology with
mouse genetics provided the first evidence that impaired
binding of BCLXL to BAK due to mutation of Glu75 of
BAK (amutant generated randomly during ENUmutagen-
esis in mice not affecting its structure or binding to direct
activator BH3-only proteins and killing potential in vitro)
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is sufficient to trigger spontaneous cell death uponMCL1
inhibition in mouse embryonic fibroblasts (MEFs). Impor-
tantly, loss of BAK–BCLXL interaction triggered a number
of in vivo phenotypes associated usually with loss of
BclxL in vivo, including T-cell loss and reduced platelet
life span (Lee et al. 2016). This study also provides some
evidence that BAK can act as an activator of BAX in
some settings, an interesting idea proposed earlier (Ma
et al. 2014). Overall, this suggests that sequestration of
BAK by BCLXL is much more critical for keeping cells
alive than preventing BAK from becoming directly acti-
vated by BH3-only proteins. These findings are consistent
with other studies proposing a unifying or hierarchical
model of BCL2 protein function (Llambi et al. 2011;
Chen et al. 2015) and also a recent report by Dai et al.
(2015), who observed that drug sensitivity of hematopoiet-
ic cancers correlates well with the oligomeric state and
the amount of BAK present in a cell rather than with the
ability of BAK to engage direct activators, such as BIM
or PUMA. Perhaps all of these interactions between
BH3-only proteins and prosurvival BCL2 proteins serve
only one higher purpose: facilitating direct interactions
of BAX with BAK.
Furthermore, BAX or BAK can spontaneously accumu-
late at and permeabilize the MOM in the absence of any
of the proteins previously reported to possess direct acti-
vation potential (i.e., BID, BIM, and PUMA as well as un-
related p53 and Rb) when all prosurvival proteins present
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Figure 1. Signaling cascades implicated in
developmental cell death and tissue homeo-
stasis. Prevention of classic apoptosis path-
ways by genetic deletion of Bax and Bak
(intrinsic) or impaired death receptor (DR)
signaling (extrinsic) does not lead to major
developmental abnormalities during em-
bryogenesis or in surviving adults. Hence,
additional cell death pathways have been im-
plicated in the removal of excess cells during
development. These pathways may involve
caspases (green boxes) or not (blue boxes).
Caspase-dependent cell death modalities in-
volve apoptosis, ultimately engaging effector
caspases 3, 6, and 7 and immunologically si-
lent cell death that ultimately leads to corpse
removal by phagocytes. Pyroptosis—a path-
way activated by Caspases 1 and 11 in innate
immune cells, mainly macrophages—leads
to the cleavage of Gasdermin D and possibly
othermembers of this family that ultimately
triggers plasma membrane rupture. Lyso-
somal cell death involves lysosomal mem-
brane permeabilization (LMP) and can be
induced by several triggers, such as Ca2+
overload, H2O2, extensive DNA damage, or
possibly evenDR signaling, leading to the re-
lease of cathepsins. These enzymes were re-
ported to trigger either a necrotic,
apoptotic, or apoptosis-like response, e.g.,
by involving the BCL2 family protein BID.
Accordingly, caspase-dependent as well as
caspase-independent forms of lysosomal
cell death have been reported. Entosis is a
cell death that is triggered by signals from
neighboring cells expressing E-cadherins or
α-catenin, and those cells are engulfed, fol-
lowed by phagosome-to-lysosome fusion,
leading to cell degradation. Necroptosis is
characterized by the activation of RIPK3
and phosphorylation ofMLKL. It requires engagement of cell surface receptors, such as toll-like receptor 4 (TLR4), TNFR familymembers,
or the interferon receptor (IFN). Engagement of these or other intracellular receptors, includingDAI or TLR3, under conditionswhereCas-
pase 8 is inhibited triggers necroptosis. Caspase 8 can cleave and thereby inhibit RIPK1/RIPK3, which are needed to activateMLKL’s pore-
forming potential, leading to plasmamembrane rupture during necroptosis. Programmed necrosis is induced by excess of Ca2+, increased
reactive oxygen species (ROS) levels, or heavy metals, causing persistent mitochondrial membrane permeabilization through the mito-
chondrial permeability transition (MPT) pore that spans both the inner and outer mitochondrial membrane. Finally, ferroptosis is trig-
gered by deprivation of cysteine, leading to glutathione (GSH) depletion and inhibition of the detoxifying enzyme GPX4, thereby
causing lipid peroxidation and plasma membrane rupture by so-far undefined mechanisms.
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are effectively neutralized. Of note, literally all known
BH3-only proteins can be rendered to become direct acti-
vators at least in vitro, depending on experimental condi-
tions (Du et al. 2011; Chen et al. 2015). Hence, it is even
more surprising that this autoactivation also happens in
the absence of any known BH3-only protein ever reported
to be involved in mitochondrial apoptosis or autophagy
(O’Neill et al. 2016). While these studies do not complete-
ly exclude an accelerating or modulatory role of direct in-
teraction of some BH3-only proteinswith BAX or BAK in a
given cellular- or stimulus-dependent context, it challeng-
es the universal validity of the “direct activation/embed-
ded together” models. It also points to the existence of
so-far undefined membrane components, possibly even
of lipid origin, that suffice to promote BAX or BAK dime-
rization and subsequent pore formation. As such, interro-
gation of protein–protein and lipid–protein interactions in
the context of the BAX/BAK pore can be expected to yield
new insights into the molecular biology of MOMP.
Along this line, despite the rather absolute apoptosis re-
sistance phenotype of cells lacking BAX and BAK (see be-
low), we need to keep in mind that the putative BAX-like
family member BOKmight be a mediator of mitochondri-
al apoptosis, as it can exert pore-forming properties in cer-
tain contexts. Work over the last few years has indicated
that BOK functions may partly overlap with those of
BAX/BAK but that there might also be unique roles to
this still poorly understood family member. Regarding
its proapoptotic functions, it remains to be clarified
whether BOK can directly form pores in the MOM and,
if confirmative, of what nature these pores are. For exam-
ple, is the intermediate of the elusive BOK pore a dimer?
BOK-induced membrane activity so far has been shown
only in artificialmembranes (liposomes), and proteasomal
degradation of BOK, regulated by members of the ERAD
pathway, was also put forward recently as a major means
of controlling (proapoptotic) BOK activity (Llambi et al.
2016), yet, in several tissues, BOK is found readily ex-
pressed (Ke et al. 2012). However, more in-depth biophys-
ical analyses, preferably within a lipid membrane
environment (as done for BAX) (for example, see Bleicken
et al. 2014), are necessary to determine the protein–pro-
tein interactions, composition, size, and stability of pores.
This would also allow one to determine whether mem-
bers of the BCL-2 family can cooperate with BOK (e.g.,
tBID, BAX, and BAK) or inhibit its activity (e.g., MCL-1
and BFL-1/A1). Furthermore, solving the three-dimen-
sional structure in the membrane-bound conformation
is a prerequisite to advance our understanding of the mo-
lecular events regulating BOK activation.
What have we learned about developmental cell
death from the analysis of BH3-only knockout mouse
mutants?
BH3-only proteins are considered to be stress-induced pro-
teins and stimulus-dependent initiators of mitochondrial
apoptosis that depend on the presence of BAX or BAK to
execute their function (Wei et al. 2001). Despite remain-
ing issues on how these proteins ultimately activate apo-
ptosis, it is generally accepted that some BH3-only
proteins are more potent killers than others: These in-
clude BIM, BID, and PUMA, which can bind to all prosur-
vival homologs with comparable affinity, while NOXA,
BAD, BMF, DP5/HRK, and BIK/BLK, on the other hand,
are believed to act mainly as auxiliary prodeath proteins
by helping to sequester BCL2 and the like; however,
BCL2 like protein BAK activator BH3-only protein
Cytochrome c BAX derepressor BH3-only protein
„retrotranslocation“ /„embedded together“ model„direct activation“ model
apoptotic stimuli
„neutralization“ model
A B C
apoptotic stimuliapoptotic stimuli
Figure 2. Models for the activation of BAX/BAK and apoptotic pore formation at the MOM. (A) The neutralization model proposes that
BAX and BAK are sequestered in their active form by BCL2 prosurvival proteins and that apoptotic stimuli lead to the recruitment of BH3-
only proteins by either post-translational stabilization or transcriptional induction. These BH3-only proteins then bind to BCL2-like pro-
teins, thereby releasing BAX/BAK, which are intrinsically active. (B) The “direct activation”model implies that BAX or BAK needs to be
directly engaged by “activator BH3-only” proteins in order to impose a conformational change needed for dimerization and subsequent
oligomerization. In order to inhibit the initiation of apoptosis, BCL2 proteins sequester activator BH3-only proteins to prevent BAX/BAK
activation. Binding of BCL2 to sensitizer BH3-only proteins (e.g., BAD,HRK, BMF) is needed to free activator BH3-only proteins (BIM, BID,
and PUMA) to activate BAXor BAK. (C ) The embedded togethermodel implies that BCL2-like proteins sequester BH3-only proteins at the
MOM, thereby inhibiting their interaction with and direct activation of BAK/BAX. In theMOM, BCL2-like proteins themselves also pre-
vent dimerization and pore formation of BH3-only protein-activated/embedded BAX/BAK monomers. Additionally, the retrotransloca-
tion concept proposes that BAX (and also BAK with slower kinetics) is in an equilibrium and is extracted from the MOM in a BCL2/
BCLX-dependent manner and shuttled back into the cytoplasm, where it oscillates between an autoinhibitory dimer and a monomeric
state. Only the latter is able to translocate to the mitochondria, where it needs to accumulate in order to form an active dimer that
can then form the apoptotic pore upon oligomerization.
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among those, NOXA recently has been assigned direct
BAX/BAK-activating potential (Chen et al. 2015). Since
such properties have also been assigned to BMF before
(Du et al. 2011), a strict discrimination of two groups of
BH3-only proteins appears difficult.
Substantial redundancy between BH3-only proteins has
been observed in in vitro analyses and gene targeting stud-
ies in mice exploring the consequences of loss of one or a
combination of BH3-only proteins (Table 1). Therefore, it
became evident that Bim is probably the most critical
member of the family, as single deletion of this gene has
themost pronounced effects of all BH3-only protein genes
studied in isolation (Pinon et al. 2008).Most strikingly, ab-
lation of Bim causes the loss of approximately half of the
progeny before embryonic day 10.5 (E10.5) in mouse de-
velopment (Bouillet et al. 1999). The basis for this phe-
nomenon and its partial penetrance is still unclear but
may be related to the observation that FGF4-driven recep-
tor tyrosine kinase signaling in trophoblast stem (TS) cells
limits BIM protein levels, thereby setting the balance be-
tweenTS cell proliferation and differentiation in early em-
bryogenesis (Yang et al. 2006).
AdultBim−/− animals show themost profound develop-
mental defects within the hematopoietic system, display-
ing severe lymphoid hyperplasia. Increased secretion of
immunoglobulins (Igs), including autoantibodies, by ac-
cumulating plasma cells leads to fatal kidney disease in
∼50% of 1-yr-old Bim−/−mice (Bouillet et al. 1999). These
effects were found ameliorated upon backcrossing onto a
C57BL/6 genetic background, but cell death-resistance
phenotypes of leukocytes and lymphadenopathy persist-
ed. Importantly, loss of only one allele can prevent lym-
phopenia and polycystic kidney disease observed in
mice lacking Bcl-2, while loss of both alleles are needed
to prevent melanocytes from dying (Bouillet et al. 2001).
Thus, BIM seems to be a crucial player in regulating apo-
ptosis during kidney development, in hair follicle stem
cells, and in the hematopoietic system. Concerning the
latter, BIM is necessary for not only the deletion of auto-
reactive B and T lymphocytes during development (Bouil-
let et al. 2002; Enders et al. 2003; Villunger et al. 2004)
but also the termination of T-cell- and B-cell-mediated
immune responses (Hildeman et al. 2002; Pellegrini
et al. 2003), affinity maturation (Fischer et al. 2007), or
the survival of granulocytes (Villunger et al. 2003b).More-
over, it also acts as a gatekeeper, preventing cancer in re-
sponse to oncogenic stress, as exemplified in the
accelerated onset of c-MYC-driven lymphomas in the ab-
sence of a single allele of Bim (Egle et al. 2004; Frenzel
et al. 2010).
Although, BIM-deficient cells show profound protec-
tion from a number of apoptotic stimuli, such as cytokine
withdrawal and ionomycin or steroid treatment, they still
remain sensitive to Fas ligation, etoposide treatment, or γ
irradiation (Bouillet et al. 1999). These observations al-
ready suggested that apoptosis following DNA damage
is regulated by other BH3-only proteins. Shortly thereaf-
ter, the p53 up-regulated modulators of apoptosis,
PUMA (Nakano and Vousden 2001; Yu et al. 2001) and
NOXA/PMAIP (Oda et al. 2000), two BH3-only proteins
induced by p53, were first described. NOXA seems to be
less critical in this process, since its deletion does not im-
pair apoptosis upon DNA damage in most cell types (Vil-
lunger et al. 2003a) but protected gastrointestinal
epithelial cells from the consequence of high-dose γ irradi-
ation in vivo (Shibue et al. 2003). Of note, keratinocytes
and fibroblasts are significantly protected from UV-medi-
ated cell death in its absence (Naik et al. 2007). Interest-
ingly, NOXA might also play a role in immunity, as
Noxa−/− mice were reported to show defects in the selec-
tion of high-affinity antigen receptors upon activation of T
and B cells (Wensveen et al. 2010, 2012) and in emergency
hematopoiesis (Wensveen et al. 2011). Loss of Puma, on
the other hand, protects hematopoietic (stem) cells (Labi
et al. 2010; Michalak et al. 2010), hepatocytes, and gastro-
intestinal epithelium (Qiu et al. 2008, 2011) effectively
from genotoxic stress and γ irradiation (Happo et al.
2010), while combined loss of Puma and Noxa further in-
creases radio resistance in some cell types, such as mouse
oocytes (Michalak et al. 2008; Kerr et al. 2012). Interest-
ingly, only the combined deletion of Puma, Noxa, and
Bim provides protection to an extent comparable with
p53 deficiency, at least in MYC-driven lymphoma cells
(Happo et al. 2010), even though BIM is not a direct target
of p53. The latter suggests the existence of a cross-talk be-
tween theDNA damage response and BIM,most likely in-
volving activation of JNK signaling (Pinon et al. 2008).
Notably, PUMA-deficient lymphocytes are also refrac-
tory to certain p53-independent apoptotic stimuli such
as dexamethasone or growth factor deprivation (Jeffers
et al. 2003; Villunger et al. 2003a), and compoundmutants
lacking BIM and PUMA reveal synergistic functions of
these proteins in cell death induction (Erlacher et al.
2006). However, no additional developmental defects
were noted in Bim−/−Puma−/− mice when compared
with Bimmutant mice (Erlacher et al. 2006). with the ex-
ception of a more pronounced lymphadenopathy and
more severely compromised deletion of autoreactive T
cells (Gray et al. 2012). More recently, it has been shown
that Puma−/− mice display an increase in adipocyte size
and increased serum leptin levels. Accordingly, food in-
takewas reduced during a high-fat diet; however, no differ-
ences in body mass and glucose metabolism were
observed, probably due to reduced physical activity com-
pared with control mice (Litwak et al. 2016). However, it
is difficult to put the observed phenotype in a develop-
mental context, as the used mouse model had PUMA de-
leted in all somatic cells. Of note, PUMA has also been
associated with glucose-induced cell death of pancreatic
islets (McKenzie et al. 2010), maintaining the interest
for this protein in diabetes- and obesity-associated
research.
BID is a particular BH3-only protein because it is the
only member of the subfamily that is intrinsically struc-
tured and needs to be cleaved by caspases, most common-
ly by caspase 8, for activation (Li et al. 1998; Luo et al.
1998). As such it connects the extrinsic and intrinsic apo-
ptosis signaling pathways in certain cell types that rely on
efficient neutralization of XIAP to generate above-thresh-
old caspase activity upon death receptor (DR) ligation (Jost
Apoptosis in development and tissue homeostasis
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Table 1. Phenotypic characteristics of BH3-only protein loss-of-function mutants
Gene Developmental and other cell death phenotypes Reference
Bim Approximately 50% of embryos die before E10; survivors
show lymphoid hyperplasia; perturbed thymic development;
leukocytes protected from a range of apoptotic stimuli;
increased serum immunoglobulin (Ig) levels and
autoantibodies; Ig deposit-driven kidney disease; impaired
deletion of autoreactive T and B cells; defective termination
of anti-viral immune responses; impaired affinity maturation
during germinal center reaction; delayed duct formation;
impaired late stage involution phenotype in the mammary
glands
Bouillet et al. 1999, 2002; Hildeman et al. 2002; Enders
et al. 2003; Pellegrini et al. 2003; Villunger et al. 2003b;
Fischer et al. 2007; Mailleux et al. 2007; Schuler et al.
2016
Bmf Normal embryonic development; lymphocytes and MEFs
partially protected from glucocorticoid or histone
deacetylase inhibition (HDACi)-induced apoptosis; mild B-
cell hyperplasia; potential overlap with BIM in mammary
gland involution
Labi et al. 2008; Hubner et al. 2010; Sakamoto et al.
2016; Schuler et al. 2016
Bid Normal embryonic development; hepatocytes resist FasL-
induced and TNF-induced hepatitis; delayed apoptosis upon
FasL or TNF-α treatment in MEFs; pancreatic β cells resist
death receptor (DR) killing; reduced response to the DNA-
damaging agents (controversial); neurons more protected
from ischemic cell death (controversial)
Yin et al. 1999; Plesnila et al. 2001; Sax et al. 2002;
Kamer et al. 2005; Zinkel et al. 2005; Kaufmann et al.
2007, 2009; McKenzie et al. 2008; Engel et al. 2010
Bad Normal embryonic development; minor protection from
apoptotic stimuli; modest reduction in B-cell proliferation in
response to mitogens; decreased production of IgG upon
immunization; prolonged platelet life span; reduced
sensitivity to TNF-induced hepatitis (controversial);
impaired glucose stimulated insulin secretion and
glucokinase activity
Danial et al. 2003; Ranger et al. 2003; Kelly et al. 2010;
Yan et al. 2013; Ottina et al. 2015
Puma Normal embryonic development; hematopoietic and
nonhematopoietic cell types highly resistant to genotoxic
stress and γ irradiation as well as growth factor deprivation;
high-fat-diet-fed as well as chow diet-fed mice show
decreased food intake and ambulatory capacity
Jeffers et al. 2003; Villunger et al. 2003a; Labi et al.
2010; Michalak et al. 2010; Litwak et al. 2016
Noxa Normal embryonic development; minor protection from
p53-dependent apoptotic stimuli; shifted T- and B-cell
receptor repertoire upon antigenic challenge; impaired stress
erythropoiesis; fibroblasts and keratinocytes resist UV
radiation
Shibue et al. 2003; Villunger et al. 2003a; Naik et al.
2007; Wensveen et al. 2012, 2013a,b
Hrk/Dp5 Normal embryonic development; sensory neurons less
sensitive to NGF withdrawal; protection from high-fat-diet-
induced loss of glucose tolerance and increased pancreatic β-
cell mass
Coultas et al. 2007; Cunha et al. 2012
Bik Normal embryonic development; no overt cell death
phenotype
Coultas et al. 2004
Bim/Puma Reduced survival of embryos, as in Bim−/− mice; lymphatic
hyperplasia exceeds that observed in Bim−/− mice; increased
resistance to apoptosis when compared with Bim mutants;
no exacerbation of autoimmunity observed compared with
Bim−/− mice despite increased impairment in the deletion of
autoreactive thymocytes
Erlacher et al. 2006; Gray et al. 2012
Bim/Bad Phenocopies Bim−/− mice with a slight increase in
lymphocytes and increased protection of B cells and
thymocytes from some apoptotic stimuli
Kelly et al. 2010
Bim/Bid Phenocopies Bim−/− mice; reduced responsiveness to TNF-
induced hepatitis when compared with single mutants
Willis et al. 2007; Kaufmann et al. 2009
Bim/Bik Phenocopies Bim−/− mice regarding development; infertile
males due to defective spermatogenesis (later than in Bax-
deficient mice)
Coultas et al. 2005
Bim/Bmf Born at reduced frequency, similar to Bim−/− mice; webbed
feet; increased incidence of vaginal atresia (65%) and
malocclusion of the incisors (25%); increased resistance of
Hubner et al. 2010; Labi et al. 2014; Woess et al. 2015;
Sakamoto et al. 2016
Continued
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et al. 2009). As a consequence, hepatocytes or pancreatic β
cells from BID-deficient mice are insensitive to Fas liga-
tion in vivo (Yin et al. 1999). Neurons from Bid−/− mice
were reported to better resist ischemic cell death that
can involve caspase 8-activating ligands of theTNF family
(Plesnila et al. 2001). However, the latter has been a mat-
ter of debate (Engel et al. 2010). Furthermore, BID has been
reported to be a p53 target, and Bid−/−MEFswere suggest-
ed to be more resistant to DNA-damaging agents (Sax
et al. 2002). Along this line, it is interesting to note that
BID can be phosphorylated by ATM and has been reported
to affect S-phase checkpoint stringency and mitochondri-
al reactive oxygen species (ROS) production (Kamer et al.
2005; Zinkel et al. 2005; Kaufmann et al. 2007), yet the
role of BID in theDNAdamage response remains disputed
(Kaufmann et al. 2007). The combined deletion of BIM and
BID did not cause any developmental abnormalities or
phenotypes that exceed those observed in BIM mutant
mice, with the notable exception that double-knockout
(DKO) mice were protected from TNF-driven fulminant
hepatitis more than single-mutant mice, placing BID
and BIM downstream from TNFR signaling in hepato-
cytes (Kaufmann et al. 2009).
In an attempt to phenocopy BAX/BAK mutant mice
(discussed below) in support of the direct activationmodel
of BH3-only protein function, mice lacking BID, BIM, and
PUMA were generated (Ren et al. 2010). However, ulti-
mately, these triple-mutant (triple-knockout [TKO])
mice did not mimic combined loss of BAX and BAK, as in-
dicated, e.g., by the fact that the rate of perinatal lethality
and certain developmental phenotypes, such as persisting
interdigital webbing and vaginal atresia, were clearly less
pronounced and less penetrant than in BAX/BAK DKO
mice (Ren et al. 2010). Furthermore, a follow-up publica-
tion by the very same group showed that TKO MEFs are
less resistant to apoptosis induction than BAX/BAK
DKO MEFs, and deletion of NOXA on top of BID, BIM,
and PUMA (QKO) was required to generate comparable
death resistance phenotypes in response to some but not
all stimuli tested (Chen et al. 2015). The latter suggests
that any of the remaining BH3-only proteins in TKO
mice may become an activator of cell death in the right
context.
Deletion of any of the other BH3-only proteins on their
own failed to reveal key roles in development, and only
minor roles in cell death signaling were observed. The
synergistic potential of these “less potent” BH3-only pro-
teins can be observed best when looking at loss-of-func-
tion studies on a BIM-deficient background. While BMF-
deficient mice show only mild phenotypes, including B-
cell-restricted lymphadenopathy and reduced sensitivity
of lymphoid cells to glucocorticoids or histone deacety-
lase inhibitors (Labi et al. 2008; Grespi et al. 2010), the
combined loss of BMF and BIM leads to pronounced devel-
opmental abnormalities, including webbed feet, vaginal
atresia, and malocclusion of the incisors (Hubner et al.
Table 1. Continued
Gene Developmental and other cell death phenotypes Reference
thymocytes and pre-B cells to dexamethasone, HDACi, and
tunicamycin when compared with Bim−/− but not in mature
T cells; enhanced B-cell lymphadenopathy; altered κ/l light
chain Ig ratio; increased serum Ig levels; high incidence of
glomerulonephritis and spontaneous tumor formation;
impaired regression of ductal mammary epithelium during
involution; restores B-cell development in the absence of
BAFF signaling
Bmf/Bad No developmental abnormalities; B-cell lineage cellularity
increased; reduced latency to spontaneous tumor formation
Baumgartner et al. 2013
Bik/Noxa Normal embryonic development; cross with Eµ-Myc
transgenic mice did not accelerate lymphoma development
compared with wild type
Happo et al. 2012
Puma/
Noxa
Normal embryonic development; slightly better protection
of lymphocytes and MEFs from γ irradiation in vitro and in
vivo
Michalak et al. 2008
Bim/Puma/
Noxa
No differences compared with BIM/PUMA double knockout
(DKO) reported; triple-knockout (TKO) cells show protection
from DNA damage similar to that seen in p53−/− mice
Happo et al. 2010
Bim/Puma/
Bid
Limited similarity to BAX/BAK DKO mice/cells in some
experimental settings; imperforate vaginal canal and
persistent webbing reported
Ren et al. 2010
Bim/Puma/
Bid/Noxa
No additional developmental deficiencies on top of BIM/
PUMA/BID TKO reported; increased protection of small
intestine from γ irradiation, exceeding that of TKO mice and
resembling BAX/BAK deficiency; protection form apoptosis
comparable with that seen in BAX/BAK DKO in response to
some but not all stimuli tested; frequency of surviving
animals still higher than in BAX/BAK DKO mice
Chen et al. 2015
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2010; Labi et al. 2014). Additionally, increased lymphade-
nopathy, higher serum Ig levels, and a higher incidence of
glomerulonephritis and malignant disease, leading to pre-
mature lethality, were observedwhen comparedwith BIM
mutantmice (Labi et al. 2014;Woess et al. 2015). BMF also
supports BIM in promoting mammary epithelial cell
death during organ morphogenesis (Mailleux et al. 2007;
Schmelzle et al. 2007) and the late stage of involution after
the cessation of lactation, a classic example of develop-
mental apoptosis (Sakamoto et al. 2016; Schuler et al.
2016).
Another prominent example for cell type-specific re-
dundancy of BH3-only proteins is BIK, the first protein
to be identified in this class (Boyd et al. 1995). BIK has
been shown to reside at the endoplasmic reticulum (ER),
where it might be involved in the transfer of Ca2+ to mito-
chondria. Although expressed at significant levels in sev-
eral tissues, no overt phenotype or cell death deficit could
be observed in mice lacking Bik (Coultas et al. 2004).
However, BIK codeletion with BIM causes infertility in
males due to perturbed spermatogenesis, resembling the
phenotype of BAX-deficient mice, although the block in
spermatogenesis occurs somewhat later in their develop-
ment (Coultas et al. 2005). Notably, no additive cell death
effects were observed when BIK and NOXA were code-
leted (Happo et al. 2012).
Despite intensive research since its early discovery, the
cell death function of the BH3-only protein BAD (Yang
et al. 1995) remains somewhat elusive. BAD deficiency
itself does not cause any aberrations in embryonic devel-
opment, although Bad−/−mice were reported to show im-
paired B-cell function and develop diffuse large B-cell
lymphoma with increased incidence (Ranger et al. 2003).
Subsequent reports suggested a role in platelet life span
(Kelly et al. 2010) and as regulator of glucose-induced insu-
lin secretion and gluconeogenesis upon phosphorylation
of its BH3 domain, precluding its binding to BCL2 (Danial
et al. 2003, 2008; Gimenez-Cassina et al. 2014). Findings
that BAD-deficient mice are less sensitive in a model of
systemic TNF-mediated hepatitis (Yan et al. 2013) could
not be confirmed in an independent study (Ottina et al.
2015). Of note, responses to TNF or glucose are strongly
influenced by the genetic background of themousemodel
used and, when poorly controlled for, can contribute to
sometimes inconsistent findings (Leiter 2002; Vanden
Berghe et al. 2015). Combined deletion of BAD plus BIM
(Kelly et al. 2010) or BMF (Baumgartner et al. 2013), re-
spectively, did not result in any particular developmental
phenotypes and revealed only mildly increased cell death
resistance upon cytokine withdrawal, B-cell-specific
lymphadenopathy, and increased susceptibility to sponta-
neous as well as radiation-induced tumorigenesis.
Finally, deletion of Dp5/Hrk, a BH3-only family mem-
ber that is expressed mainly in the central and peripheral
nervous system (Imaizumi et al. 1997), does not impair
neuronal development, although sensory neurons derived
from these mice are less sensitive to nerve growth factor
withdrawal ex vivo (Coultas et al. 2007). HRK-deficient
mice were also reported to be protected from high-fat-
diet-induced loss of glucose tolerance and displayed in-
creased pancreatic β-cell mass (Cunha et al. 2012); howev-
er, this phenotype awaits independent confirmation.
In summary, these studies point toward a large degree of
redundancy among the BH3-only proteins in developmen-
tal cell death and substantial flexibility regarding their use
and requirement in stress-induced apoptosis. Based on the
reported phenotypes in single and compound BH3-only
protein mouse mutants, the general relevance of mito-
chondrial cell death for organ development in the embryo
and tissue homeostasis in the adultmust be strongly ques-
tioned. Certainly, it remains possible that the combined
deletion of all BH3-only proteins listed above may pheno-
copy BAX/BAK mutant mice, but, given the assumption
that not all of these proteins have exclusive roles in apo-
ptosis but also intersect, e.g., with the regulation of mito-
chondrial dynamics or the autophagy machinery, data
interpretation will remain difficult.
Defining the role of mitochondrial cell death
in development by loss-of-function analysis in mice
lacking BAK, BAX, BOK, or combinations thereof
BAXandBAK loss-of-functionmutants have been generat-
ed early on but failed to reveal major developmental de-
fects (Table 2). BAX mutant mice showed mild cell death
resistance of neurons to trophic factor deprivation ex
vivo, an increase in neurons and lymphocytes, and, para-
doxically, male sterility due to increased spermatogonia
death, halting spermatogenesis (Knudson et al. 1995;
Deckwerth et al. 1996; White et al. 1998; Fan et al. 2001).
BAKmutantmice showed no discernable defects in devel-
opment or mitochondrial or DR-mediated apoptosis. In
striking contrast, mice lacking both genes showed signifi-
cant developmental defects and a severe impairment in
cell death in response to a broad range of apoptotic triggers.
Most BAX/BAK DKO mice died perinatally, and only
<10% of mice survived to adulthood (Lindsten et al.
2000).Ofnote, clear developmental phenotypes associated
with defective developmental apoptosis, such as a persis-
tent interdigitatingmesenchyme and an imperforate vagi-
nal canal, were observed. Furthermore, these mice also
showed neurological deficits, as seen by circling behavior
and frequent seizuresupon stress.Unresponsiveness to au-
ditory stimulation indicated deafness, and pups frequently
died after a few days, often showing suckling defects and
social isolation from littermates (Lindsten et al. 2000).
The neurological defects were associated with excess
numbers of undifferentiated cells in the periventricular
zone, and follow-up studies documented massive lymph-
adenopathy in surviving or fetal liver-reconstituted mice
(Lindsten et al. 2000; Rathmell et al. 2002), increased neu-
ronal progenitor cell number in situ (Lindsten et al. 2003),
and persisting fetal ocular vasculature and inner retinal
cells, including rod photoreceptors, which normally die if
they fail to migrate to the outer retina (Hahn et al. 2002,
2003). However, formation of other organs—including
the kidney, heart, liver, lung, pancreas, or bladder—ap-
peared to develop and function normally in the surviving
mice (Lindsten et al. 2000; Lindsten and Thompson
Tuzlak et al.
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2006). This raises the possibility that the development of
theseorgansmaynotbe linkedtodevelopmental apoptosis
or that alternative means to induce apoptosis or other
forms of developmental cell death are engaged (Fig. 1).
One such cell death mediator might be BOK; however,
apart from overexpression data, physiological evidence
for a proapoptotic role of BOK is still meager. No develop-
mental abnormalities or spontaneous phenotypes were
reported for the firstBok gene-deficientmousemodel gen-
erated, and hematopoietic cells derived from these mice
were normally sensitive to classical apoptotic stresses
(Ke et al. 2012). Along that line, Bok−/−Bax−/− and
Bok−/−Bak−/− doubly deficient mice displayed no ex-
acerbated phenotype over Bax or Bak single-deficient
mice, respectively, with the exception of increased oocyte
numbers in aged Bok−/−Bax−/− females (Ke et al. 2013).
The latter findingmaypoint towarda role of BOKinoocyte
apoptosis thatwarrants further investigation.Recently,Ke
et al. (2015) also reported amore pronounced phenotype in
lymphocytes in the peripheral blood ofmice reconstituted
with Bok−/−Bax−/−Bak−/− TKO hematopoietic stem cells
compared with Bax−/−Bak−/− DKO controls, indicating
that BOK may have redundant functions with BAX and
BAK in this compartment. This is an interesting observa-
tion, taking into account the lowBOKexpression inmouse
hematopoietic cells (Ke et al. 2012). Maybe not surprising,
a comparison of DKO and TKO lymphocytes failed to
reveal any differences in response to various apoptosis in-
ducers, given that DKO cells were already fully protected.
It is conceivable thatmorepronounced effectsmaybe seen
during development or in the adult organism in TKO
tissues that are normally high in BOK expression, and a
thorough analysis of embryogenesis inTKOmice or condi-
tional deletion of all three genes in a given tissue is eagerly
awaited.
Mitochondrial apoptosis and its role in early
embryogenesis
Despite the fact that loss of individual BH3-only proteins
or combinations thereof points toward rate-limiting roles
in tissuehomeostasis in adults, bestdocumented in thehe-
matopoietic system, the phenotypes observed are, at sec-
ond thought, rather minor (Table 1). The same holds true
Table 2. Phenotypic characteristics of Bax/Bak/Bok loss-of-function mutants
Gene Developmental and other cell death phenotypes Reference
Bax Mild lymphoid hyperplasia; infertile males due to
disordered seminiferous tubules; increase in number of
several neuron types during embryogenesis; behavioral
deficits affecting learning, socio-sexual behavior, and
anxiety; greater locomotor activity but greater
immobility times in forced swimming test; depression-
like traits
Knudson et al. 1995; White et al. 1998; Fan et al.
2001; Sun et al. 2004; Jyotika et al. 2007; Lee et al.
2009; Luedke et al. 2013; Krahe et al. 2015
Bak1 Normal development; no abnormalities or age-related
disorders
Lindsten et al. 2000
Bok No apparent developmental phenotype; resistance to
ER stress (controversial)
Ke et al. 2012; Carpio et al. 2015, 2016; Fernandez-
Marrero et al. 2016; Llambi et al. 2016
Bax/Bak1 Perinatal death of >90% DKO mice; surviving mice
show interdigital webbing; imperforation of the vagina;
accumulation of excess cells in the CNS and
hematopoietic systems; neurologic abnormalities
include deafness; circling behavior; suckling defects;
palate cleft; surviving fetal ocular vasculature; extra rod
photoreceptors
Lindsten et al. 2000, 2003; Rathmell et al. 2002;
Hahn et al. 2003, 2005; Lindsten and Thompson
2006
Baxfl/−Bak1−/−,
CD19Cre, or
MxCre
Accumulation of B cells at all stages, but MZ B cells
and B-1 cells are normal; defect in cell cycle
progression upon stimulation with LPS and anti-IgM;
cell death resistance
Takeuchi et al. 2005
Baxfl/flBak1−/− Reduced myocardial infarction area; apoptosis and
necrosis resistance phenotypes
Whelan et al. 2012; Karch et al. 2013
α-MHC-Cre,
Albumin-Cre, or
Nestin-Cre
Protection from radiation damage Ren et al. 2010
Baxfl/flBak1−/−,
Villin-cre, or
Tie2-Cre
No improvement of survival after high-dose IR-induced
gastrointestinal syndrome; protection form IR-induced
bone marrow failure
Kirsch et al. 2010
Bok/Bax
Bok/Bak1
No phenotype exacerbating Bax or Bak single
deficiency, except increased oocyte numbers in Bok/
Bax females
Ke et al. 2013
Bok/Bak1/Bax Mildly more severe phenotype in leukocytes of mice
reconstituted with TKO fetal liver compared with Bax/
Bak1 DKO controls; craniofacial defects (facial cleft)
Ke et al. 2015; Carpio et al. 2016
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when considering that some Bax−/−Bak−/− mice can sur-
vive to adulthood (Lindsten andThompson 2006), and chi-
mericmice carrying a reconstitutedhematopoietic system
lackingBAX/BAKandBOKdevelop“only”gradual lymph-
adenopathy with signs of autoimmunity but not cancer or
inflammatory phenotypes due to excess leukocytes (Ke
et al. 2015). Based on this and the fact that most BAX/
BAK-deficient mice die perinatally only by largely unex-
ploredcauses,weneed toconclude thatcell deathobserved
early in embryogenesis does not necessarily involve mito-
chondria or, alternatively,may bemediated by alternative
factors that can promote MOMP. It is worth mentioning
here that, in most vertebrates, cell death is not observed
prior to gastrulation (Penaloza et al. 2006). However, in
mammals, such as mice, cell death occurs already at the
morula stage during compaction as well as during blasto-
coel formation and differentiation of the inner cell mass
(ICM) in the early blastocyst (Zakeri et al. 2005; Busso
et al. 2010). Why, then, is development not perturbed in
the absence of BAX/BAK? One is tempted to argue here
that an excess of cells of the ICM can be tolerated easily
at that early stage, as we also introduce extra embryonic
stem cells into the blastocyst in the process of generating
gene-modified mice. Perhaps cell death in the blastocyst
stage embryo is simply not critical for development or
may not follow classic routes. Excess cells in BAX/BAK
DKO blastocysts have not yet been demonstrated but
might be cleared by other means; for example, cell canni-
balization via entosis (Krishna and Overholtzer 2016) or
nonprofessional phagocytosis by neighboring cells upon
exposure of “eat me” signals (Arandjelovic and Ravichan-
dran2015).Certainly, a failure to clear dyingcells fromem-
bryoid bodies—e.g., observed in the context of ATG5 or
Beclin-1 deficiency—blocks cavitation (Qu et al. 2007),
suggesting that lackof cell death and accumulationof cells
at that stage should do the same. Clearly, this process does
not seem perturbed in the absence of BAX/BAK. However,
aficionados of alternativemodes of cell death, such as nec-
roptosis,may find it intriguing that general caspase inhibi-
tion by z-VAD-FMK or selective inhibition of caspase 8
halts the development of the preimplantation embryo
(Zakeri et al. 2005; Busso et al. 2010). In fact, caspase inhi-
bition even enhances rates of cell death normally observed
in the ICMinvitro.However,whether this deathoccurs by
necroptosis is yet unclear (Fig. 1).
Taken together, it seems that timed removal of excess
cells of the ICM in the early preimplantation development
of the embryo is either not mediated by BAX/BAK, com-
pensated by alternative types of death, or simply well tol-
erated and balanced by other means (e.g., reduced
proliferation rates or phagocytic clearance mechanisms).
Interestingly, lack of Bax/Bak appears to delay the differ-
entiation of embryonic stem cells upon retinoic acid treat-
ment or embryoid body or teratoma formation by blocking
CD95-mediated cell death of less differentiated cells
(Wang et al. 2015). The notion that limited caspase activ-
ity—most likely generated by caspase 8 temporarily acti-
vating caspase 3 (Fujita et al. 2008)—seems required for
proper blastocyst formation in vitro is certainly interest-
ing but somewhat confounded by the fact that, in the ab-
sence of Casp8, embryogenesis halts only around E10.5
due to defective angiogenesis (Varfolomeev et al. 1998),
whileCasp3-deficient mice can come to term (Honarpour
et al. 2000; Zheng et al. 2000), meaning that preimplanta-
tion development is not affected by lack of caspase activ-
ity.Whether BAX/BAK can generate such caspase activity
in the absence of caspase 8 needs to be analyzed, but it is
worth mentioning that caspase 6 can also cleave RIPK1
(van Raam et al. 2013) and could hence put a halt to nec-
roptosis in the early embryo when caspase 8 is absent.
Following similar lines of thought, tube formation in
the embryo is crucial to the normal development of
many organs, including the mammary glands, kidneys,
and lungs, the latter two developing normally in BAX/
BAK DKO mice. Tube formation can be achieved by the
closure of an epithelial sheet layer (e.g., neural tube and
primitive gut) or by lumen formation involving cell clear-
ance in a compact cell mass, also known as cavitation
(female reproductive tract and exocrine glands). In mouse
embryos, the first cavitation event happens shortly
prior to gastrulation, converting the solid embryonic ecto-
derm into a hollow egg cylinder, thereby generating the
proamniotic cavity, surrounded by a single epithelial
cell layer (Coucouvanis and Martin 1995). The basic prin-
ciples observed at that stage most likely reflect what is
happening in organogenesis later many times. The cell
death observed at that stage shows classic hallmarks of ap-
optosis (DNA laddering and pyknotic nuclei) and is in-
duced by cues generated from the visceral endoderm,
while the columnar epithelium is rescued from death by
signals generated from its interaction of the basement
membrane (i.e., integrin signaling) (Coucouvanis and
Martin 1995; Murray and Edgar 2000). This type of cell
death is hence highly reminiscent of what is often referred
to in the cell death field as “anoikis,” which is induced
upon loss of contact with the extracellular matrix or ex-
pulsion of cells from the epithelium (e.g., in the gastroin-
testinal tract). This death is blocked by BCL2
overexpression or loss of certain BH3-only proteins
(Schmelzle et al. 2007) and hence is supposedly dependent
on BAX/BAK. Again, this process must progress normally
in their absence in the early embryo, as it occurs during lu-
men formation in many other organs during embryogene-
sis, e.g., in the kidneys, lungs, or heart. It deserves
mentioning here that caspase 8 has been implicated in
anoikis and lumen formation before (Frisch and Screaton
2001). Although this has been deemed controversial, one
may speculate that caspase 8 might well play a critical
role in development, in particular when BAX and BAK
are missing. Whether the surviving DKO mice have im-
paired duct formation in exocrine glands, such as the
mammary gland, remains unexplored.
Mitochondrial apoptosis as a regulator of tissue
homeostasis in the adult
Tissue-specific codeletion of Bax and Bak, usually
achieved by conditional deletion of Bax on a Bak−/− back-
ground, raises the question of whether mitochondrial
Tuzlak et al.
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apoptosis is critical for homeostasis in the adult. For ex-
ample, Bax/Bak codeletion in the gastrointestinal tract
using Villin-Cre does not cause spontaneous tissue hyper-
plasia, documenting that cell death of gastrointestinal ep-
ithelial cells can happen in the absence of mitochondrial
apoptosis, and tissue homeostasis is effectively main-
tained in its absence (Kirsch et al. 2010). This is also sup-
ported by the fact that surviving DKOmice have not been
reported to develop hyperplasia in the gastrointestinal
tract. It remains possible, though, that shedding of cells
from the tips of villi and their excretion together with fe-
ces are sufficient to maintain gut homeostasis.
Also, in tissues with a low proliferative index, like the
brain (Ren et al. 2010), heart, and liver (Whelan et al.
2012; Karch et al. 2013), BAX and BAK seem dispensable
for homeostasis, as their codeletion does not seem to trig-
ger a hyperplastic phenotype in these organs (Table 2).
This may be less of a surprise, as the promoters driving
Cre expression to delete Bax on a Bak-deficient back-
ground usually stem from genes that associatewith termi-
nal differentiation. As the mitotic index and rate of post-
mitotic cell death in these organs are known to be low,
the observation time in these studies may not have been
long enough to reveal developing organ deficits. Alterna-
tively, mechanisms other than mitochondrial apoptosis
may compensate to maintain organ homeostasis. It
will certainly be of interest to monitor such conditional
mouse mutants long term or expose them to challenges
that associatewith tissue regeneration that needs to be ba-
lanced by cell death induction; e.g., upon recovery from
partial hepatectomy.
Taken together, all of these findings challenge textbook
dogma about the importance of apoptosis in embryonic
development or tissue homeostasis. As deletion of BAX
and BAK effectively protects many cell types from death
induced by diverse apoptosis-inducing agents and signal-
ing cues but only causes modest changes in adult tissue
homeostasis and embryogenesis, alternative explanations
are needed.
As quickly touched on before, such an explanation
might be redundancy with BOK. However, expression of
Bok mRNA in tissue from BAX and BAK single or com-
pound knockout mice as well as BOK protein in tissue
from BAX or BAK single-knockout mice appears, on the
whole, unaffected, arguing against compensatory effects,
as do studies combining BAX or BAK deficiency with
loss of BOK (Ke et al. 2012, 2013). The fact thatmice recon-
stituted with Bax/Bak/Bok TKO hematopoiesis showed
increased lymphocyte numbers in peripheral blood and a
higher infiltration rate of lymphocytes into the gut may
also be explained by loss of other processes, as published
data also point toward nonapoptotic roles of BOK, such
as in trophoblast proliferation (Ray et al. 2010). Even pro-
tective roleshavebeen reported forBOK. It has been shown
that Bok cells can be more sensitive to the Golgi/ER-
impacting drug brefeldin A, presenting with a defective
IRE1α-mediated stress response and enhanced apoptosis
(Echeverry et al. 2013). Likewise, D’Orsi et al. (2016)
reported Bok-deficient neurons to be more sensitive to
oxygen/glucose deprivation-induced or seizure-induced
neuronal injury. In essence, these findings point toward
nonapoptotic or even protective roles of BOK at the ER.
Certainly, it will be very interesting to see whether the
Bax/Bak/Bok triple deficiency affects embryogenesis
more severely than loss of BAK and BAX in tissues that
do express discernable levels of BOK, such as the ovaries,
uterus, or gastrointestinal tract (Ke et al. 2012). However,
whether putative changes are related to impaired cell
death due to lack of BOKneeds to be thoroughly validated.
Redundancies between cell death modalities as a means
to control developmental cell death?
Assuming that the analysis of the above-mentioned TKO
mice will not provide a universally satisfying answer to
the question of whether mitochondrial apoptosis is
strictly essential and uniquely required for embryogenesis
and organ homeostasis, the follow-up question would be:
What cell death mechanisms could contribute to the de-
velopment of or compensate for Bax/Bak/Bok deficiency
in tissue homeostasis? While it was easy to speculate
why cells die when caspase activation is inhibited in the
presence of MOMP, this will require entirely different
thinking, looking at developmental cell death in the ab-
sence of BAX/BAK/BOK. In the first case, it is quite easy
to accept that energy depletion, breakdown of membrane
gradients, and solute influx in cells undergoing MOMP in
a quantitative manner ultimately trigger cellular demise
even in the absence of caspase activation, with features
of programmed necrosis (Miyazaki et al. 2001; Tait and
Green 2008). This was also confirmed by observations
made in embryos surviving loss of Apaf-1, Caspase 9, or
Caspase 3 and managing to come to term (Honarpour
et al. 2000; Zheng et al. 2000). Thesemice have cleared tis-
sues usually removed by apoptotic mechanisms during
development. Consistently, necrosis-like morphology of
interdigital cells was observed in embryonic limb buds
that were allowed to develop in culture in the presence
of pharmacological caspase inhibitors (Chautan et al.
1999). This is in line with the notion that none of the re-
ported mouse strains lacking caspases that are required
for apoptosis exhibits soft-tissue syndactyly (Wang and
Lenardo 2000). This suggests that, in some cell types
and tissues, programmed necrosis can compensate for im-
pairedmitochondrial apoptosis or that caspases can be en-
gaged in a noncanonical manner during development, as
suggested by observations that lymphocytes lacking
Apaf-1 or Caspase 9 can still undergo BCL2-regulated
apoptosis (Marsden et al. 2002).
Although necrotic cell death can clearly be pro-
grammed in response to certain types of stress, such as is-
chemia/reperfusion injury in the kidney or heart, Ca2+
overload, or excitotoxicity in neurons, where necrosis
plus secondary inflammatory cytokine-driven apoptosis
frequently contributes to tissue damage (Linkermann
et al. 2014), we do not have strong evidence that pro-
grammed necrosis contributes to organ development.
This may be simply due to a lack of understanding of
the underlying molecular machinery (Karch and
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Molkentin 2015). The only gene confirmed so far to be
rate-limiting in this process is cyclophilin D (CypD), a
peptidylprolyl isomerase present in the mitochondrial
matrix, which controls mitochondrial permeability tran-
sition (MPT). However, although mice lacking CypD
show reduced programmed necrosis in ischemia models,
embryogenesis is not perturbed (Schinzel et al. 2005).
Clearly, defects in MPT pore (MTP) opening do not im-
pair apoptosis. Recently, a structural contribution of BAX
and BAK that differs from their pore-forming potential
driving MOMP has been proposed to be required for pro-
grammed necrosis upon MTP opening, e.g., in response
to H2O2, Ca
2+ overload, or heavy-metal poisoning (Tisch-
ner et al. 2012; Karch et al. 2013). Most strikingly, MEFs
and liver mitochondria isolated from Bax/Bak DKO
mice showed clear deficits inMTP activity and codeletion
of Bax/Bak in the heart (αMHC-Cre) protected from coro-
nary artery ligation-induced myocardial infarction, an
insult usually associated with rapid ATP depletion con-
verting apoptotic death into necrosis involving MTP
(Karch et al. 2013). Interestingly, however, conditional
deletion of Bax on a Bak/CypD DKO background yielded
comparable results and not a higher degree of protection,
as anticipated (Whelan et al. 2012). Hence, these studies
provide evidence that BAX/BAK contribute to MTP-driv-
en programmed necrosis in some settings. Importantly,
this activity does not require their oligomerization poten-
tial but rather their mitochondrial fusion potential, as
fragmented mitochondria, like those found in BAX/
BAK-deficient cells, have a deficit in MTP opening.
Hence, the MTP-opening defect could be ameliorated by
addition of an inhibitor of mitochondrial fission (Whelan
et al. 2012). The investigators also conclude that BAX/
BAK may actually form the outer constituent of the elu-
sive MTP complex that is needed to promote solute entry
and organ swelling during necrosis. However, assuming
that this is indeed the case and that BAX/BAK can control
apoptosis plus programmed necrosis at the same time, the
rather mild phenotypes observed in BAX/BAK-deficient
embryos would represent consequences of impairment
of both cell death pathways, excluding a major role for
MTP and programmed necrosis in embryogenesis.
Whether other proteolytic enzymes, such as cytosolic
calpains or lysosomal cathepsins,may be needed to trigger
death in the absence of BAX/BAK is more difficult to as-
sess, as these enzymes are members of large families,
some of which are essential for embryogenesis (Repnik
and Turk 2010; Smith and Schnellmann 2012). Calcium-
regulated calpains have been implicated repeatedly in
cell death associated with neurodegenerative disorders,
such as amyotrophic lateral sclerosis ormultiple sclerosis,
but not necessarily developmental cell death (Smith and
Schnellmann 2012), although m-calpain mutant embryos
fail to implant (Dutt et al. 2006). In contrast, induction of
lysosomal cathepsins and their subsequent release have
been reported to precede interdigital cell death in avian
limb buds, and up-regulation of cathepsin D has also
been observed in the limb buds of mouse embryos. Simul-
taneous pharmacological inhibition of caspases and ca-
thepsins delayed mesodermal cell death in chicken
limbs more potently than caspase inhibition alone
(Zuzarte-Luis et al. 2007). Furthermore, a critical role of
cathepsins B and L has been reported in mammary gland
remodeling during involution (Kreuzaler et al. 2011), al-
though its physiological role remains disputed (Sakamoto
et al. 2016). Regardless, these observations again support
the idea that mitochondrial apoptosis is not solely re-
sponsible for developmentally programmed cell death in
vertebrates but works in conjunction with, or can be com-
pensated for by, other cell killing mechanisms.
Based on available data today, components of the DR
pathway of apoptosis are equally unlikely to compensate
for mitochondrial cell death during embryonic develop-
ment, althoughunrestrained necroptosis causes embryon-
ic lethality in animals lacking FADD, FLIP, or Caspase
8. This excess cell death that destroys the vasculature of
the embryo, leading to developmental arrest around
E10.5 (Varfolomeev et al. 1998; Yeh et al. 1998, 2000),
can be fully rescued by codeletion of RIPK3 or MLKL,
the key driver and effector of necroptosis, respectively.
FADD/MLKL-deficient and Caspase 8/MLKL-deficient
mice, which lack literally all DR-mediated apoptosis as
well as programmed necroptosis are born at a normal
Mendelian frequency and show no developmental abnor-
malities, as domice lacking FADD plus RIPK3 or Caspase
8 plus RIPK3 (Kaiser et al. 2011; Oberst et al. 2011; Alva-
rez-Diaz et al. 2016; Zhang et al. 2016). Tissue homeosta-
sis also appears unaffected in thesemice, with one notable
exception, the hematopoietic compartment, which gradu-
ally expands and provokes fatal autoimmunity in aged
mice (Alvarez-Diaz et al. 2016; Zhang et al. 2016). As
such, all of these mutants mimic the pathology noted in
lpr mutant mice that lack functional FAS/CD95 but
develop normally otherwise (Watanabe-Fukunaga et al.
1992). Synergy between mitochondrial and DR-mediated
apoptosis has been reported before as being critical for im-
mune response termination (Hughes et al. 2008; Weant
et al. 2008). Whether they cooperate during development
needs to be investigated.
The generation of BAX/BAKDKOmice that lackMLKL
or RIPK3 may reveal unexpected insight regarding the po-
tential redundancy between these cell death pathways in
embryogenesis. However, as MLKL-deficient (Murphy
et al. 2013) or RIPK3-deficient (Newton et al. 2004) mice
do not show developmental phenotypes, one would need
to speculate that BAX/BAK can compensate well for their
absence in cell death initiation during embryogenesis.
However, this is unlikely, as BCL2 overexpression or
loss of BAX/BAK fails to block MLKL-driven cell death,
and activation of BAX/BAK does not trigger necrosome
formation (Pasparakis and Vandenabeele 2015). Whether
BAX/BAK-deficient embryos show increased rates of in-
flammation due to nonapoptotic cell death—e.g., via ne-
crosis that may then activate MLKL-driven necroptosis
—remains to be sorted out. Clearly, simultaneous dele-
tion of RIPK3 mediated necroptosis, requiring MLKL for
execution, and CypD, which is required for regulated ne-
crosis by theMTP, does not impair embryogenesis and tis-
sue homeostasis (Linkermann et al. 2013). Whether
simultaneous inhibition of several of these cell death
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pathways—e.g., in a BAX/BAK/MLKL/CYPD/CASP8
compound mutant mouse—will halt embryogenesis in
its tracks needs to be investigated in the future by those
who can afford the involved mouse work. But what about
other pore-forming complexes that can kill cells, such as
Caspase 1/11-activated Gasdermin D (Ding et al. 2016;
Liu et al. 2016)? Is this killing machinery really exclusive
for innate immune cells? What about ferroptosis? This
cell death process is regulated by the antioxidant enzyme
glutathione peroxidase 4 (GPX4), which depends on gluta-
thione to prevent toxic iron-dependent lipid peroxidation
and cell death (Yang and Stockwell 2016). Of note, ferrop-
tosis inhibition can ameliorate developmental defects
noted in the absence of MDM2 when the canonical effec-
tor functions of p53 are impaired (Jiang et al. 2015). Hence,
under certain conditions, this type of cell death can be-
come activated during embryogenesis.
However, in timesofCRISPR/CAS9-mediatedgeneedit-
ing of mouse embryos, those with the necessary resources
at hand may find these intriguing possibilities to explore.
Regardless of the phenotype of such “multi-CRISPR” em-
bryos, establishing a direct link to absence of cell death of
any kind will be challenging. Clearly, signals emanating
from dying cells serve as a cue to control proliferation, mi-
gration, or differentiation during development, and sepa-
rating cause from consequence and phenotype will be
difficult. Do we need cell death execution at all to clear
superfluous cells? Perhaps the exposure of certain engulf-
ment signals suffices to clear cells during organogenesis.
In the end,wemay learnyet again thatnature finds itsway.
Conclusions and perspectives
Given that work on BCL2 family proteins has been over-
whelming in its quantity in the past decades and that
apoptosis hasmade it into every cell biology and embryol-
ogy textbook as a key regulator of development and tissue
homeostasis, it is surprising how little we actually do
know about its actual relevance for these processes. One
is tempted to say that (cell) death is not an essential part
of life after all, which might sound comforting but ulti-
mately must be wrong. We all know it. Of course, this
may in part be due to the fact that cell death events during
vertebrate and in particular mammalian development are
difficult to follow and study. Regardless, keeping in mind
that there are still huge gaps in our knowledge of what
controls cavitation and duct and organ formation during
embryonic development and how homeostasis is main-
tained in the adult in the absence of mitochondrial apo-
ptosis, particularly outside the hematopoietic system,
we can anticipate that research along these lines will still
be rewarding. We may find not only novel regulators of
these developmental processes but also valuable new in-
sights for human disease.
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